Therapy-induced senescence: Friend or foe?

被引：0
|
作者：
Stewart, Sheila
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-WS2-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
WS2-3
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Erythropoietin in Stroke Therapy: Friend or Foe
    Souvenir, Rhonda
    Doycheva, Desislava
    Zhang, John H.
    Tang, Jiping
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (10) : 1205 - 1213
  • [42] Radiation-induced pulmonary fibrosis: roles of therapy-induced senescence and microRNAs
    Prasanna, Pataje G. S.
    Aryankalayil, Molykutty
    Citrin, Deborah E.
    Coleman, C. Norman
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2023, 99 (07) : 1027 - 1036
  • [43] Nicotine replacement therapy: A friend or foe
    Devi, Rajkumari E.
    Barman, Diplina
    Sinha, Shruti
    Hazarika, Suranjana J.
    Das, Sreeparna
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (06) : 2615 - 2620
  • [44] A re-view of cellular senescence: friend or foe of tumorigenesis ?
    Bischof, Oliver
    Dejean, Anne
    Pineau, Pascal
    M S-MEDECINE SCIENCES, 2009, 25 (02): : 153 - 160
  • [45] Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
    Kallenbach, Julia
    Roozbahani, Golnaz Atri
    Horestani, Mehdi Heidari
    Baniahmad, Aria
    CELL AND BIOSCIENCE, 2022, 12 (01):
  • [46] Therapy-Induced Senescence Is a Predictor of Treatment Outcome in Acute Myeloid Leukemia
    Schonlein, Martin
    Dabritz, J. Henry M.
    Fan, Dorothy Ngo-Yin
    Ihlow, Jana
    Schwarzer, Rolf
    Vick, Binje
    Spiekermann, Karsten
    Burmeister, Thomas
    Westermann, Jorg
    Jeremias, Irmela
    Schmitt, Clemens A.
    BLOOD, 2017, 130
  • [47] Therapy-induced senescence in melanoma cells is associated with a low proinflammatory secretome
    Homann, L.
    Rentschler, M.
    Brenner, E.
    Boehm, K.
    Weidemann, S.
    Roecken, M.
    Wieder, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S193 - S193
  • [48] Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma
    Gleason, Caroline E.
    Dickson, Mark A.
    Klein , Mary E.
    Antonescu, Cristina R.
    Gularte-Merida, Rodrigo
    Benitez, Marimar
    Delgado, Juliana I.
    Kataru, Raghu P.
    Tan, Mark Wei Yi
    Bradic, Martina
    Adamson, Travis E.
    Seier, Kenneth
    Richards, Allison L.
    Palafox, Marta
    Chan, Eric
    D'Angelo, Sandra P.
    Gounder, Mrinal M.
    Keohan, Mary Louise
    Kelly, Ciara M.
    Chi, Ping
    Movva, Sujana
    Landa, Jonathan
    Crago, Aimee M.
    Donoghue, Mark T. A.
    Qin, Li-Xuan
    Serra, Violetta
    Turkekul, Mesruh
    Barlas, Afsar
    Firester, Daniel M.
    Manova-Todorova, Katia
    Mehrara, Babak J.
    Kovatcheva, Marta
    Tan, Nguan Soon
    Singer, Samuel
    Tap, William D.
    Koff, Andrew
    CLINICAL CANCER RESEARCH, 2024, 30 (04) : 703 - 718
  • [49] Untargeted Lipidomics Highlight the Depletion of Deoxyceramides during Therapy-Induced Senescence
    Millner, Alec
    Lizardo, Darleny Y.
    Atilla-Gokcumen, Curies Ekin
    PROTEOMICS, 2020, 20 (10)
  • [50] Drug tolerant persister cancer cells escape therapy-induced senescence
    Fortier, Anne-Marie
    Topolski, Jason
    Alzial, Gabriel
    Monast, Anie
    Kuasne, Hellen
    Zuo, Dongmei
    Pacis, Alain
    Deblois, Genevieve
    Park, Morag
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
12345